Benchmark Maintains Buy on MaxLinear, Lowers Price Target to $23
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst David Williams maintains a Buy rating on MaxLinear (NASDAQ:MXL) but lowers the price target from $35 to $23.
October 26, 2023 | 4:14 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Benchmark analyst maintains a Buy rating on MaxLinear but lowers the price target from $35 to $23.
The news is directly related to MaxLinear. While the Buy rating is maintained, the lowering of the price target could indicate a potential decrease in the short-term performance of the stock. However, the impact is not necessarily negative as the Buy rating is still in place.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100